BioHarv
PrivateLast Round
Series D
Mar 11, 2026
Est. Valuation
$9B
Total Funding Raised
$852.02M
Company Overview
BioHarv is a biotechnology company developing battery-free, energy-harvesting implantable sensors for continuous cardiac monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioHarv Comps
Public and private peers based on sector, stage, and business model.
BioHarv Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Mar 11, 2026 | ||||
| Series C | Jul 30, 2025 | ||||
| Series B Extension | Apr 25, 2023 | ||||
| Series B | Dec 8, 2021 | ||||
| Series A | Feb 18, 2021 | ||||
Seed | Oct 22, 2018 |
BioHarv Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series D, Series A, Seed |
| SV Angel | Series B Extension |
| Georgian | Series D |
| Khosla Ventures | Series B Extension |
| Craft Ventures | Series D |
| Okta Ventures | Series D |
| Accenture Ventures | Series D |
BioHarv Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about BioHarv's valuation, stock price, and market status.
